Skip to main content

Table 1 Clinical characteristics of the synovial sarcoma cohort

From: Release of circulating tumor cells and cell-free nucleic acids is an infrequent event in synovial sarcoma: liquid biopsy analysis of 15 patients diagnosed with synovial sarcoma

Case Sitea Sizeb (cm) Therapy Site of metastasis Size of recurrencec (cm) Subtype
1 right leg 5.5 SX + ChT mpx lung, bone, CNS no recurrence monophasic
2 left ankle 4 SX + ChT lung no recurrence biphasic
3 lung NA SX + ChT lung no recurrence biphasic
4 gluteal region 7 SX + ChT no metastasis no recurrence monophasic
5 left hand 1 SX + ChT mpx lung 2.8 monophasic
6 left praesacral region NA SX + ChT mpx lung 4 monophasic
7 left leg NA SX + ChT mpx lung, liver 3 monophasic
8 abdominal wall 10 SX + ChT no metastasis 3.5 monophasic
9 right palm 3 SX no metastasis 1.5 biphasic
10 neck NA SX + RT + ChT no metastasis no recurrence monophasic
11 left forearm NA SX + ChT lung 2.1 monophasic
12 right forearm 3.9 SX + ChT mpx lung, mediastinum no recurrence monophasic
13 right popliteal region 10 SX + ChT mpx lung, kidney NA monophasic
14 right sole 5 SX + ChT no metastasis no recurrence monophasic
15 left leg NA SX + ChT mpx lung, pleura, mediastinum no recurrence biphasic
  1. alocation of the primary tumor; bmaximum diameter of the primary tumor; cmaximum diameter of the recurrent tumor; NA not available, SX surgical excision, ChT chemotherapy, RT radiotherapy, mpx multiplex, CNS central nervous system. Chemotherapy means the combination of the following agents: Epirubicin; VIP: 3 cycles of Etoposide, Ifosfamide and Cisplatin; Bisphosphonate; Dacarbazine; Vincristine; Pazopanib; Doxorubicin; Ifosfamide; Gemcytabine; Docetaxel; Carboplatin; Etoposide; CYVADIC: Cyclophosphamide, Vincristine, Adriamycin, Dacarbazine